Company Filing History:
6 out of 850 
1 out of 196 
1 out of 5,469 
Years Active: 2008-2024
Title: The Innovative Contributions of Andrew I. Damokosh in Cancer Therapy
Introduction: Andrew I. Damokosh, based in West Hartford, CT, is a prominent inventor known for his significant contributions to cancer therapy through his innovative approaches and patented technologies. With a total of six patents to his name, his work focuses on improving the identification, assessment, and treatment of cancer patients, ultimately aiming to enhance patient outcomes.
Latest Patents: Among Andrew I. Damokosh’s latest patents are two groundbreaking inventions. The first patent addresses methods for the identification of predictive markers to determine whether cancer patients will respond to therapeutic regimens prior to treatment. This invention emphasizes the importance of specific predictive markers, allowing for personalized treatment strategies that optimize the likelihood of reducing tumor growth rates in clinical settings. The second patent also focuses on cancer therapy, particularly in identifying predictive markers that can indicate expected short-term or long-term survival times for patients. By analyzing the expression levels of these markers, healthcare providers can better predict patient outcomes and tailor treatments accordingly.
Career Highlights: Throughout his career, Andrew has worked with prominent organizations, including Millennium Pharmaceuticals Limited and the University of Texas System. His experiences in these reputable institutions have undoubtedly enriched his expertise in the field of cancer research and therapy.
Collaborations: Andrew I. Damokosh has collaborated with notable individuals in his field, including Barbara M. Bryant and George J. Mulligan. Working alongside such accomplished colleagues has provided valuable insights and fostered innovative solutions to complex challenges in cancer treatment.
Conclusion: Andrew I. Damokosh’s commitment to advancing cancer therapy through his inventions exemplifies the transformative potential of innovation in medicine. His patents not only enhance our understanding of patient responsiveness to treatments but also enable healthcare professionals to make informed decisions that can significantly impact patient survival and quality of life. His contributions continue to inspire advancements in the field and offer hope to many individuals affected by cancer.